212 related articles for article (PubMed ID: 1592036)
1. Serum copper and zinc levels in epileptic children with valproate treatment.
Kaji M; Ito M; Okuno T; Momoi T; Sasaki H; Yamanaka C; Yorifuji T; Mikawa H
Epilepsia; 1992; 33(3):555-7. PubMed ID: 1592036
[TBL] [Abstract][Full Text] [Related]
2. The effects of antiepileptic drugs on serum zinc and copper levels in children.
Sözüer DT; Barutçu UB; Karakoç Y; Yalçin E; Onen S
J Basic Clin Physiol Pharmacol; 1995; 6(3-4):265-9. PubMed ID: 8852271
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term therapy with sodium valproate on nail and serum trace element status in epileptic children.
Armutcu F; Ozerol E; Gurel A; Kanter M; Vural H; Yakinci C; Akyol O
Biol Trace Elem Res; 2004; 102(1-3):1-10. PubMed ID: 15621922
[TBL] [Abstract][Full Text] [Related]
4. The changes of serum zinc, copper, and selenium levels in epileptic patients: a systematic review and meta-analysis.
Jia W; Song Y; Yang L; Kong J; Boczek T; He Z; Wang Y; Zhang X; Hu H; Shao D; Tang H; Xia L; Xu X; Guo F
Expert Rev Clin Pharmacol; 2020 Sep; 13(9):1047-1058. PubMed ID: 32856976
[TBL] [Abstract][Full Text] [Related]
5. Plasma trace element, plasma glutathione peroxidase, and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy.
Kürekçi AE; Alpay F; Tanindi S; Gökçay E; Ozcan O; Akin R; Işimer A; Sayal A
Epilepsia; 1995 Jun; 36(6):600-4. PubMed ID: 7555974
[TBL] [Abstract][Full Text] [Related]
6. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy.
Verrotti A; Basciani F; Trotta D; Pomilio MP; Morgese G; Chiarelli F
Epilepsy Res; 2002 Jan; 48(1-2):71-5. PubMed ID: 11823111
[TBL] [Abstract][Full Text] [Related]
7. Effect of anti-epileptic drugs on serum zinc and copper concentrations in epileptic patients.
Kuzuya T; Hasegawa T; Shimizu K; Nabeshima T
Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):61-5. PubMed ID: 8458677
[TBL] [Abstract][Full Text] [Related]
8. [The decreased level of plasma carnitine in patients with epilepsy].
Belousova ED
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680
[TBL] [Abstract][Full Text] [Related]
9. The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children.
Çiçek NP; Kamaşak T; Serin M; Okten A; Alver A; Cansu A
Seizure; 2018 May; 58():90-95. PubMed ID: 29679911
[TBL] [Abstract][Full Text] [Related]
10. Decreased platelet count in children with epilepsy treated with valproate and its relationship to the immature platelet fraction.
Kurahashi H; Takami A; Murotani K; Numoto S; Okumura A
Int J Hematol; 2018 Jan; 107(1):105-111. PubMed ID: 28879549
[TBL] [Abstract][Full Text] [Related]
11. Early and persistent increase in serum lipoprotein (a) concentrations in epileptic children treated with carbamazepine and sodium valproate monotherapy.
Voudris KA; Attilakos A; Katsarou E; Drakatos A; Dimou S; Mastroyianni S; Skardoutsou A; Prassouli A; Garoufi A
Epilepsy Res; 2006 Aug; 70(2-3):211-7. PubMed ID: 16781120
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
Chung S; Choi J; Hyun T; Rha Y; Bae C
J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
[TBL] [Abstract][Full Text] [Related]
13. [Hyperammonemia in valproate therapy in children and adolescents].
Laub MC
Nervenarzt; 1986 May; 57(5):314-8. PubMed ID: 3088461
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of zinc and copper in epileptic children during long-term therapy with anticonvulsants.
Talat MA; Ahmed A; Mohammed L
Neurosciences (Riyadh); 2015 Oct; 20(4):341-5. PubMed ID: 26492112
[TBL] [Abstract][Full Text] [Related]
15. Effect of sodium valproate monotherapy on serum uric acid concentrations in ambulatory epileptic children: a prospective long-term study.
Attilakos A; Voudris KA; Garoufi A; Mastroyianni S; Dimou S; Prassouli A; Katsarou E
Eur J Paediatr Neurol; 2006; 10(5-6):237-40. PubMed ID: 17035050
[TBL] [Abstract][Full Text] [Related]
16. Effect of valproic acid therapy on zinc metabolism in children with primary epilepsy.
Lerman-Sagie T; Statter M; Szabo G; Lerman P
Clin Neuropharmacol; 1987; 10(1):80-6. PubMed ID: 3102054
[TBL] [Abstract][Full Text] [Related]
17. Potential effects of valproate and oxcarbazepine on growth velocity and bone metabolism in epileptic children- a medical center experience.
Lin CM; Fan HC; Chao TY; Chu DM; Lai CC; Wang CC; Chen SJ
BMC Pediatr; 2016 May; 16():61. PubMed ID: 27142370
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS.
Nakajima Y; Ito T; Maeda Y; Ichiki S; Kobayashi S; Ando N; Hussein MH; Kurono Y; Sugiyama N; Togari H
Brain Dev; 2011 Nov; 33(10):816-23. PubMed ID: 21196091
[TBL] [Abstract][Full Text] [Related]
19. Thyroid function with antiepileptic drugs.
Isojärvi JI; Pakarinen AJ; Myllylä VV
Epilepsia; 1992; 33(1):142-8. PubMed ID: 1733749
[TBL] [Abstract][Full Text] [Related]
20. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
Kim SH; Chung HR; Kim SH; Kim H; Lim BC; Chae JH; Kim KJ; Hwang YS; Hwang H
Neuropediatrics; 2012 Jun; 43(3):135-9. PubMed ID: 22618302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
